Monday, September 14, 2026

Tracking Teacher Mental Health: U.S. and Japan vs. South Korea

South Korea's Ministry of Education discusses mandatory mental health screenings for teachers after a tragic incident.

Bio-Revolution: Celltrion’s $700M Biosimilar Is Reshaping the Global Drug Market

Celltrion's breakthrough in antibody biosimilars is transforming healthcare, enhancing access and innovation in treatment options.

Exploring the New North Korea-Russia Hospital: A Game Changer for Medical Tourism in Wonsan?

Russia and North Korea begin construction of a Friendship General Hospital in Wonsan, enhancing medical cooperation and tourism support.

Tag: stem cell therapy

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

“Why Can’t Stem Cell Treatments Be Offered in Korea?”…Government Maps Out a “Korean Model of Regenerative Medicine”

The debate over stem cell therapy highlights why it's available in Japan but not in South Korea.

Patients Travel Overseas for Cell Therapies—South Korea Moves to Lower Barriers to Treatment

South Korean patients seek stem cell therapies abroad due to limited options at home, despite high costs and uncertain efficacy.

Regenerative Medicine Expanded to Four Diseases Including Knee Osteoarthritis; Medipost and CHA Biotech Seen as Potential Beneficiaries

The Korean government is easing regulations on regenerative medicine, boosting biotech, and enabling patient access to validated therapies.

Hospitals Fuel South Korea’s Stem Cell Treatment Boom, but Experts Call for Stronger Patient Safeguards

South Korea's stem cell therapies expand rapidly, but lack regulation and clinical evidence, raising patient concerns about treatment choices.

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Stem Cell Therapies Face Long Road to Market Despite Decades of Promise

Stem cell therapies show promise for treating diseases, but face significant commercialization challenges, including quality control and funding.

U.S., Japan and China Advance Stem Cell Commercialization While Korea Works to Close Gaps

The global stem cell therapy market is rapidly growing, but South Korea faces challenges in commercialization compared to the U.S. and Japan.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

Why 20 Years of Stem Cell Therapy Research Still Lacks Proven Results

Stem cell therapy shows promise but faces hurdles in clinical applications and approvals, with few successful treatments available.

Revolutionizing Regenerative Medicine: How Noul’s AI Blood Analysis is Transforming Stem Cell Treatments

Noul partners with Infinite Medical to enhance its AI blood analysis tool, miLab™ BCM, for stem cell regenerative therapies.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Unlocking the Future of Healthcare: How Adaptive Clinical Trials Can Transform Regenerative Medicine in Asia

The article discusses South Korea's efforts to ease regulations on regenerative medicine to improve patient access while addressing significant challenges.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.